Tag: ResMed

SAN DIEGO – ResMed is taking another step to diversify its product offerings, as well as boost its digital health presence, with its recently announced acquisition of mementor, says CEO Mick Farrell.  mementor, which is based in Leipzig, Germany, develops and sells digital medical products and has the only permanently listed digital health application in sleep medicine that is reimbursed by statutory insurances in the country.  “As we consider opportunities to address...

PITTSBURGH – Philips Respironics is alerting users of certain CPAP or Bi-Level PAP therapy masks with magnetic headgear clips or straps that these devices should not be used by or near patients and their household members, caregivers and bed partners who have metallic implanted devices or metallic objects (such as metallic splinters) in the body.   The magnetic headgear clips are used to attach the headgear straps to the masks, a commonly used method in sleep therapy devices.  This...

SAN DIEGO – More than 480 million people worldwide likely suffer from chronic obstructive pulmonary disease or COPD, according to a new abstract led by ResMed and presented on Sept. 4 at the European Respiratory Society Congress. This figure is 22% to 126% higher than today’s most cited estimates of 212 million to 392 million. “This number should be a warning,” said study co-author and ResMed Chief Medical Officer Carlos M. Nunez, M.D. “It should urge doctors to be more...

SAN DIEGO – ResMed has officially opened a new technology R&D facility in Sandyford in Dublin, alongside Tánaiste Leo Varadkar, to support innovation, technology development and product development. The company is investing 30 million euros in the facility, doubling its Ireland-based software and technology team with 70 jobs over the next four years, including high-skilled, high-paying roles such as mobile, AWS and full-stack software developers and algorithm/machine learning engineers....

SAN DIEGO – Mick Farrell’s tone has shifted slightly when it comes to ResMed increasing its market share amid a major competitor’s recall.  During a conference call to discuss the company’s fourth quarter and fiscal year 2022 financial results, the CEO said he no longer looks at it as “incremental or temporal.”  “This is permanent share taking,” he said. “We’re going to go in, we’re going to get share and we’re...

SAN DIEGO – ResMed reported revenue of $914.7 million for the fourth quarter of 2022, a 4% increase compared to the same period in 2021. It reported revenue of $3.6 billion for fiscal year 2022, a 12% increase compared to 2021. “Our fourth quarter and full-year fiscal year 2022 results demonstrate strong growth and ResMed’s market leadership,” said Mick Farrell, ResMed’s CEO. “During the quarter, we saw continued adoption of our most advanced platform innovation...

MARTINSRIED and LEIPZIG, Germany – ResMed has acquired Leipzig, Germany-based mementor in a move that strengthens its overall sleep portfolio with a digital solution for insomnia, the company says.  mementor developed and owns somnio, Germany’s first, and so far only, Digital Health Application (DiGA) for the treatment of insomnia that’s reimbursable.  “mementor is an ideal fit for ResMed Germany and, more important, millions of people across Germany who want...

MARTINSRIED and LEIPZIG, Germany – ResMed has acquired Leipzig, Germany-based mementor in a move that strengthens its overall sleep portfolio with a digital solution for insomnia, the company says.  mementor developed and owns somnio, Germany’s first, and so far only, Digital Health Application (DiGA) for the treatment of insomnia that’s reimbursable.  “mementor is an ideal fit for ResMed Germany and, more important, millions of people across Germany who want...

AMSTERDAM – A comprehensive testing and research program on the PE-PUR foam in certain CPAP, BiPAP and mechanical ventilator devices has shown very low prevalence of visible degradation, Philips announced in an update on June 28.  In first-generation DreamStation devices, which represent 68% of registered affected devices globally, testing found:   164 of 36,341 (0.5%) devices with self-reported no ozone use showed significant visible foam degradation.  777 of...

SAN DIEGO – ResMed will exhibit at Medtrade East in Atlanta, Oct. 24-26 at the Georgia World Congress Center. “Anytime we get a chance to spend time with our HME partners at an important industry event, it is a valuable opportunity for us,” says Bill Shoop, vice president, North America Sales, ResMed. “With the challenges our industry is facing right now, it's more important than ever to understand how we can best serve our HME partners and collaborate on innovative ways...